Prozac Maker Eli Lilly Just Bought a Psychedelics Company for $2.8 Billion — Here’s What It Could Mean for Mental Health
Big pharma is making a big bet that a DMT nasal spray could succeed where daily Prozac pills fall short.
Big pharma is making a big bet that a DMT nasal spray could succeed where daily Prozac pills fall short. This story matters for Business & Startups readers tracking talent. Reported by entrepreneur.com. Read the full original at the source link below.
Originally reported by entrepreneur.com. TalentNews curates and briefs the business & startups stories that matter. Our editorial policy →